Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.
Familial combined hyperlidemia (FCH) is a common metabolic disorder characterized by: (a) increase in cholesterolemia and/or triglyceridemia in at least two members of the same family, (b) intra-individual and intrafamilial variability of the lipid phenotype, and (c) increased risk of premature coronary heart disease (CHD). FCH is very frequent and is one of the most common genetic hyperlipidemias in the general population (prevalence estimated: 0.5%-2.0%), being the most frequent in patients affected by CHD (10%) and among acute myocardial infarction survivors aged less than 60 (11.3%). This percentage increases to 40% when all the myocardial infarction survivors are considered without age limits. However, because of the peculiar variability of laboratory parameters, and because of the frequent overlapping with the features of metabolic syndrome, this serious disease is often not recognized and treated. The aim of this review is to define the main characteristics of the disease in order to simplify its detection and early treatment by all physicians by mean of practical guidelines.
Gaddi
Antonio
A
Center for Metabolic diseases and Atherosclerosis, University of Bologna, Italy. gaddiats@med.unibo.it
Cicero
A F G
AF
Odoo
F O
FO
Poli
A A
AA
Paoletti
R
R
D003937:Diagnosis, Differential; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D008074:Lipoproteins / Q000097:blood; D015995:Prevalence
D008074:Lipoproteins